SLC7A11 and obesity disorder: Accordingly, AMPK activation based on the low expression of SLC7A11 altering the cellular sensitivity to ferroptosis under HFD treatment was mechanistically responsible for the distinctive antitumor activity of SGF in obesity-related CRC.